American Diabetes Association, 67th Sessions
Consult Your Provider: Always send a quick message to your clinical team before changing your routine
For context, retatrutide vs semaglutide data shows retatrutide producing roughly 50% more weight loss than the highest approved semaglutide dose
There are no membership fees, no insurance verification delays, and no surprise billing
Headache has been reported in approximately 6-8% of patients in clinical trials, though causality is often difficult to establish given the high background prevalence of headaches in the general population
Disease-modifying osteoarthritis drugs (DMOADs) are a class of agents that target key tissues involved in OA, and according to FDA guidelines, they must prevent structural progression and improve symptoms 5,59